Le Lézard
Classified in: Health
Subject: PER

Cellero Welcomes New Director of Sales to Fuel and Accelerate Expansion Plans


LOWELL, Mass., July 9, 2020 /PRNewswire/ -- Cellero, the leading provider of donor and patient collection services, GMP-grade biomaterials, characterized immune cells, and custom research services, is pleased to announce that Greg Werchowski has joined Cellero as Director of Sales. Greg's responsibilities will include sales leadership, accelerating revenue, driving business development with new customers and contributing to the company's business strategies.

Greg brings over 30 years of sales experience to the Cellero team, with 26 of those years at GE Healthcare in a variety of positions with increasing responsibility.  His tenure included roles in sales management, new business development, field sales and business unit leadership. Prior to joining Cellero, Greg gained valuable experience with customer solutions related to Radiology, Cardiology, Pharmacy, Pathology and Ambulatory segments for the North American market. He is a graduate of the University of Pittsburgh and holds an MBA from the Katz Graduate School of Business.

"Greg is an outstanding addition to the Cellero team, and he brings a deep understanding of healthcare sales and business development," said Jeffrey Allen, President and CEO of Cellero. "As Cellero continues to grow and focuses on new business opportunities across the industry, Greg's strong background will help accelerate the achievement of our strategic goals and business objectives."

"I am excited about the opportunity to work with the Cellero team and customers in the immunotherapy market segment.  The potential to help create new cell and gene therapies that improve patient lives really motivates me," said Werchowski.

ABOUT CELLERO
Cellero is the most comprehensive end-to-end provider of donor and patient collection services, GMP-grade biomaterials, characterized immune cells, and custom research and clinical laboratory services for companies developing new drugs and therapies. Cellero leverages world-class immunology research experts, coast-to-coast FDA-registered collection facilities and distribution centers, and CLIA-certified laboratories to serve scientists and drug developers in biopharmaceutical and academic institutions around the world. 

Visit www.cellero.com to learn how Cellero can be your reliable, trusted partner in advancing discovery and development of new treatments and cures in the field of cell and gene therapy.

 

SOURCE Cellero


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: